Proton magnetic resonance spectroscopy in schizophrenia.
Proton magnetic resonance spectroscopy (MRS) has become an important tool to study in vivo certain biochemical aspects of brain disorders. In the last decade this technique has been applied to the in vivo investigation of pathophysiological aspects of psychiatric disorders, extending knowledge of the related brain alterations. This review will focus on providing some background to clarify technical and biochemical issues and it will describe the studies that have been performed in schizophrenia. The results will be framed in a more general context to highlight what we have learned and what remains to be understood from the application of this technique to schizophrenia.
Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.
A
A
Bertolino
D R
DR
Weinberger
D001921:Brain / Q000378:metabolism* / Q000473:pathology; D001923:Brain Chemistry; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D011522:Protons; D012559:Schizophrenia / Q000378:metabolism* / Q000473:pathology
D011522:Protons